Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study

The Lancet Global Health

Volumn 6, Issue 3, 2018, Pages e292-e301

  Murphy, Adrianna ^a   Palafox, Benjamin ^a   O'Donnell, Owen ^b,c   Stuckler, David ^d   Perel, Pablo ^a   AlHabib, Khalid F ^e   Avezum, Alvaro ^f   Bai, Xiulin ^g   Chifamba, Jephat ^h   Chow, Clara K ⁱ   Corsi, Daniel J ^j   Dagenais, Gilles R ^k   Dans, Antonio L ^l   Diaz, Rafael ^m   Erbakan, Ayse N ⁿ   Ismail, Noorhassim ^o   Iqbal, Romaina ^p   Kelishadi, Roya ^q   Khatib, Rasha ^r   Lanas, Fernando ^s   Lear, Scott A ^t   Li, Wei ^g   Liu, Jia ^g   Lopez Jaramillo, Patricio ^u   Mohan, Viswanathan ^v   Monsef, Nahed ^w   Mony, Prem K ^x   Puoane, Thandi ^y   Rangarajan, Sumathy ^z   Rosengren, Annika ^aa   Schutte, Aletta E ^ab   Sintaha, Mariz ^ac   Teo, Koon K ^z   Wielgosz, Andreas ^ad   Yeates, Karen ^ae   Yin, Lu ^g   Yusoff, Khalid ^af   Zatońska, Katarzyna ^ag   Yusuf, Salim ^z   McKee, Martin ^a   more..

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d BOCCONI UNIVERSITY   (Italy)

^e KING SAUD UNIVERSITY   (Saudi Arabia)

^f UNIVERSITY OF SANTO AMARO   (Brazil)

^g FUWAI HOSPITAL   (China)

^h UNIVERSITY OF ZIMBABWE   (Zimbabwe)

ⁱ GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^j OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^k LAVAL UNIVERSITY   (Canada)

^l UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

^m ECLA   (Argentina)

ⁿ Nisa Hastanesi   (Turkey)

^o UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

^p AGA KHAN UNIVERSITY   (Pakistan)

^q ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^r LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^s UNIVERSIDAD DE LA FRONTERA   (Chile)

^t SIMON FRASER UNIVERSITY   (Canada)

^u Research Institute of the Fundacion Oftalmologica de Santander FOSCAL   (Colombia)

^v MADRAS DIABETES RESEARCH FOUNDATION   (India)

^w DUBAI HEALTH AUTHORITY   (United Arab Emirates)

^x ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

^y UNIVERSITY OF THE WESTERN CAPE   (South Africa)

^z MCMASTER UNIVERSITY   (Canada)

^aa SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^ab NORTH WEST UNIVERSITY   (South Africa)

^ac INDEPENDENT UNIVERSITY   (Bangladesh)

^ad UNIVERSITY OF OTTAWA   (Canada)

^ae QUEEN S UNIVERSITY   (Canada)

^af UNIVERSITI TEKNOLOGI MARA   (Malaysia)

^ag WROCLAW MEDICAL UNIVERSITY   (Poland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ARTICLE; CANADA; CARDIOVASCULAR DISEASE; CHINA; COLOMBIA; COUNTRY ECONOMIC STATUS; GROSS NATIONAL INCOME; HEALTH CARE COST; HEALTH SURVEY; HIGH INCOME COUNTRY; HUMAN; INCIDENCE; INDIA; MORTALITY RATE; NATIONAL HEALTH SERVICE; OBSERVATIONAL STUDY; PAKISTAN; PRIORITY JOURNAL; PUBLIC HEALTH; RISK FACTOR; SAUDI ARABIA; SECONDARY PREVENTION; SELF REPORT; SOCIOECONOMICS; SOUTH AFRICA; TANZANIA; ZIMBABWE; ADULT; FEMALE; GLOBAL HEALTH; HEALTH CARE DISPARITY; MALE; MIDDLE AGED; PROSPECTIVE STUDY; RURAL POPULATION; SOCIAL CLASS; STATISTICS AND NUMERICAL DATA; URBAN POPULATION;

ADULT; CARDIOVASCULAR DISEASES; FEMALE; GLOBAL HEALTH; HEALTHCARE DISPARITIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RURAL POPULATION; SECONDARY PREVENTION; SOCIAL CLASS; SOCIOECONOMIC FACTORS; URBAN POPULATION;

EID: 85044636388     PISSN: None     EISSN: 2214109X     Source Type: Journal    
DOI: 10.1016/S2214-109X(18)30031-7     Document Type: Article

References (48)

1. UN. Sustainable Development Goals. 2015, United Nations, New York http://www.un.org/sustainabledevelopment/sustainable-development-goals/ (accessed March 25, 2016).
2. Yusuf, S, Reddy, S, Ounpuu, S, Anand, S, Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 104 (2001), 2746–2753.
3. Yusuf, S, Islam, S, Chow, CK, et al. Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. Lancet 378 (2011), 1231–1243.
4. Yusuf, S, Two decades of progress in preventing vascular disease. Lancet 360 (2002), 2–3.
5. WHO. NCD global monitoring framework. 2013, World Health Organization, Geneva http://www.who.int/nmh/global_monitoring_framework/en/ (accessed Sept 1, 2016).
6. Gaziano, T, Reddy, KS, Paccaud, F, Horton, S, Chaturvedi, V, Cardiovascular disease. Jamison, DT, Breman, JG, Measham, AR, et al. (eds.) Disease control priorities in developing countries, 2nd edn., 2006, World Bank, Washington, DC.
7. Khatib, R, McKee, M, Shannon, H, et al. Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data. Lancet 387 (2016), 61–69.
8. Gupta, R, Islam, S, Mony, P, et al. Socioeconomic factors and use of secondary preventive therapies for cardiovascular diseases in South Asia: the PURE study. Eur J Prev Cardiol 22 (2015), 1261–1271.
9. Avezum A, Oliveira GB, Lanas F, et al. Secondary CV prevention in South America in a community setting: the PURE study. Glob Heart 7; 12: 305–13.
10. Schroder, SL, Richter, M, Schroder, J, Frantz, S, Fink, A, Socioeconomic inequalities in access to treatment for coronary heart disease: a systematic review. Int J Cardiol 219 (2016), 70–78.
11. Niu, S, Zhao, D, Zhu, J, et al. The association between socioeconomic status of high-risk patients with coronary heart disease and the treatment rates of evidence-based medicine for coronary heart disease secondary prevention in China: results from the Bridging the Gap on CHD Secondary Prevention in China (BRIG) project. Am Heart J 157 (2009), 709–715.
12. Jin, H, Tang, C, Wei, Q, et al. Age-related differences in factors associated with the underuse of recommended medications in acute coronary syndrome patients at least one year after hospital discharge. BMC Cardiovasc Disord, 14, 2014, 127.
13. Teo, K, Chow, CK, Vaz, M, et al. The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries. Am Heart J 158 (2009), 1–7.
14. Corsi, DJ, Subramanian, SV, Chow, CK, et al. Prospective Urban Rural Epidemiology (PURE) study: baseline characteristics of the household sample and comparative analyses with national data in 17 countries. Am Heart J 166 (2013), 636–646.
15. Rutstein, S, Johnson, K, The DHS Wealth Index. 2004, ORC Macro, Calverton, MD.
16. Filmer, D, Pritchett, LH, Estimating wealth effects without expenditure data—or tears: an application to educational enrollments in states of India. Demography 38 (2001), 115–132.
17. Vyas, S, Kumaranayake, L, Constructing socio-economic status indices: how to use principal components analysis. Health Policy Plan 21 (2006), 459–468.
18. O'Donnell, O, van Doorslaer, E, Wagstaff, A, Lindelow, M, The concentration index. Analyzing health equity using household survey data: a guide to techniques and their implementation. 2008, The World Bank, Washington, DC.
19. Wagstaff, A, The bounds of the concentration index when the variable of interest is binary, with an application to immunization inequality. Health Econ 14 (2005), 429–432.
20. Erreygers, G, Correcting the concentration index. J Health Econ 28 (2009), 504–515.
21. Chow, CK, Lock, K, Madhavan, M, et al. Environmental Profile of a Community's Health (EPOCH): an instrument to measure environmental determinants of cardiovascular health in five countries. PLoS One, 5, 2010, e14294.
22. The World Bank. World Bank development indicators. http://data.worldbank.org/data-catalog/world-development-indicators, 2017 (accessed March 21, 2017).
23. Maddox, TM, Chan, PS, Spertus, JA, et al. Variations in coronary artery disease secondary prevention prescriptions among outpatient cardiology practices: insights from the NCDR (National Cardiovascular Data Registry). J Am Coll Cardiol 63 (2014), 539–546.
24. Fang, Y, Medicine prices, availability and affordability in Shaanxi province, western China. 2012, World Health Organization and Health Action International, Geneva.
25. Victora, CG, Hallal, PC, Araujo, CL, Menezes, AM, Wells, JC, Barros, FC, Cohort profile: the 1993 Pelotas (Brazil) birth cohort study. Int J Epidemiol 37 (2008), 704–709.
26. Victora, CG, Vaughan, JP, Barros, FC, Silva, AC, Tomasi, E, Explaining trends in inequities: evidence from Brazilian child health studies. Lancet 356 (2000), 1093–1098.
27. Gwatkin, DR, Ergo, A, Universal health coverage: friend or foe of health equity?. Lancet 377 (2011), 2160–2161.
28. Macchia, A, Mariania, J, Ferrante, D, Nul, D, Grancelli, H, Doval, H, Premature cardiovascular death and socioeconomic status in Argentina. On the opportunities and challenges representing vulnerable populations. Rev Argent Cardiol 83 (2015), 506–511.
29. Mohan, VR, Muliyil, J, Mortality patterns and the effect of socioeconomic factors on mortality in rural Tamil Nadu, south India: a community-based cohort study. Trans R Soc Trop Med Hyg 103 (2009), 801–806.
30. Pednekar, MS, Gupta, R, Gupta, PC, Illiteracy, low educational status, and cardiovascular mortality in India. BMC Public Health, 11, 2011, 567.
31. Murphy, A, Mahal, A, Richardson, E, Moran, AE, The economic burden of chronic disease care faced by households in Ukraine: a cross-sectional matching study of angina patients. Int J Equity Health, 12, 2013, 38.
32. Murphy, A, Jakab, M, McKee, M, Richardson, E, Persistent low adherence to hypertension treatment in Kyrgyzstan: how can we understand the role of drug affordability?. Health Policy Plan 31 (2016), 1384–1390.
33. Bowry, AD, Shrank, WH, Lee, JL, Stedman, M, Choudhry, NK, A systematic review of adherence to cardiovascular medications in resource-limited settings. J Gen Intern Med 26 (2011), 1479–1491.
34. Kankeu, HT, Saksena, P, Xu, K, Evans, DB, The financial burden from non-communicable diseases in low- and middle-income countries: a literature review. Health Res Policy Syst, 11, 2013, 31.
35. Chatham House. Shared responsibilities for health: a coherent global framework for health financing. 2014, The Royal Institute of International Affairs, London.
36. Howard, DH, Sentell, T, Gazmararian, JA, Impact of health literacy on socioeconomic and racial differences in health in an elderly population. J Gen Intern Med 21 (2006), 857–861.
37. Castellano, JM, Sanz, G, Penalvo, JL, et al. A polypill strategy to improve adherence: results from the FOCUS project. J Am Coll Cardiol 64 (2014), 2071–2082.
38. Macinko, J, Harris, MJ, Brazil's family health strategy—delivering community-based primary care in a universal health system. N Engl J Med 372 (2015), 2177–2181.
39. Rocha, R, Soares, RR, Evaluating the impact of community-based health interventions: evidence from Brazil's Family Health Program. Health Econ 19:suppl (2010), 126–158.
40. Rasella, D, Harhay, MO, Pamponet, ML, Aquino, R, Barreto, ML, Impact of primary health care on mortality from heart and cerebrovascular diseases in Brazil: a nationwide analysis of longitudinal data. BMJ, 349, 2014, g4014.
41. Glymour, MM, Avendano, M, Can self-reported strokes be used to study stroke incidence and risk factors?: evidence from the health and retirement study. Stroke 40 (2009), 873–879.
42. Woodfield, R UK Biobank Stroke Outcomes Group UK Biobank Follow-up and Outcomes Working Group, Sudlow, CL, Accuracy of patient self-report of stroke: a systematic review from the UK Biobank Stroke Outcomes Group. PLoS One, 10, 2015, e0137538.
43. Eliassen, BM, Melhus, M, Tell, GS, et al. Validity of self-reported myocardial infarction and stroke in regions with Sami and Norwegian populations: the SAMINOR 1 Survey and the CVDNOR project. BMJ Open, 6, 2016, e012717.
44. Meisinger, C, Schuler, A, Lowel, H, Group, MK, Postal questionnaires identified hospitalizations for self-reported acute myocardial infarction. J Clin Epidemiol 57 (2004), 989–992.
45. Xavier, D, Pais, P, Devereaux, PJ, et al. Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. Lancet 371 (2008), 1435–1442.
46. Risso-Gill, I, Balabanova, D, Majid, F, et al. Understanding the modifiable health systems barriers to hypertension management in Malaysia: a multi-method health systems appraisal approach. BMC Health Serv Res, 15, 2015, 254.
47. Legido-Quigley, H, Camacho Lopez, PA, Balabanova, D, et al. Patients' knowledge, attitudes, behaviour and health care experiences on the prevention, detection, management and control of hypertension in Colombia: a qualitative study. PLoS One, 10, 2015, e0122112.
48. Hypertension Guideline Working Group, Seedat, YK, Rayner, BL, Veriava, Y, South African hypertension practice guideline 2014. Cardiovasc J Afr 25 (2014), 288–294.